Cargando…
A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease
The current recommended therapy for Kawasaki disease (KD) is the combination of intravenous immunoglobulin (IVIG) and aspirin. However, the role of corticosteroid therapy in KD remains controversial. Using meta-analysis, this study aimed to investigate the efficacy of corticosteroid therapy in KD by...
Autores principales: | Zhu, Bo-hui, Lv, Hai-tao, Sun, Ling, Zhang, Jian-min, Cao, Lei, Jia, Hong-liang, Yan, Wen-hua, Shen, Yue-ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284666/ https://www.ncbi.nlm.nih.gov/pubmed/22057683 http://dx.doi.org/10.1007/s00431-011-1585-4 |
Ejemplares similares
-
Understanding the Pathogenesis of Kawasaki Disease by Network and Pathway Analysis
por: Lv, Yu-wen, et al.
Publicado: (2013) -
Identification of differentially expressed microRNAs in acute Kawasaki disease
por: Chen, Ye, et al.
Publicado: (2018) -
Clinical characteristics of Kawasaki disease and concurrent pathogens during isolation in COVID-19 pandemic
por: Ding, Yue-Yue, et al.
Publicado: (2021) -
Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease
por: Zhao, Chun-Na, et al.
Publicado: (2016) -
MiR-223-3p Alleviates Vascular Endothelial Injury by Targeting IL6ST in Kawasaki Disease
por: Wang, Xiang, et al.
Publicado: (2019)